5 Am Venture Management, LLC Entrada Therapeutics, Inc. Transaction History
5 Am Venture Management, LLC
- $149 Million
- Q2 2025
A detailed history of 5 Am Venture Management, LLC transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, 5 Am Venture Management, LLC holds 4,308,379 shares of TRDA stock, worth $22.7 Million. This represents 19.43% of its overall portfolio holdings.
Number of Shares
4,308,379
Previous 4,408,379
2.27%
Holding current value
$22.7 Million
Previous $39.9 Million
27.35%
% of portfolio
19.43%
Previous 27.61%
Shares
2 transactions
Others Institutions Holding TRDA
# of Institutions
107Shares Held
28.8MCall Options Held
15.7KPut Options Held
0-
Baker Bros. Advisors LP New York, NY4.87MShares$25.7 Million0.33% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.38MShares$23.1 Million67.92% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.57MShares$13.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$8.94 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.6MShares$8.47 Million0.0% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $166M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...